Jack Bendheim Sells 3,520 Shares of Phibro Animal Health (NASDAQ:PAHC) Stock

Phibro Animal Health Corporation (NASDAQ:PAHC) CEO Jack Bendheim sold 3,520 shares of the firm’s stock in a transaction that occurred on Tuesday, November 4th. The stock was sold at an average price of $43.10, for a total transaction of $151,712.00. Following the completion of the transaction, the chief executive officer owned 65,920 shares in the company, valued at $2,841,152. This represents a 5.07% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Jack Bendheim also recently made the following trade(s):

• On Thursday, October 30th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $41.07, for a total transaction of $144,566.40.
• On Tuesday, October 28th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $41.56, for a total transaction of $146,291.20.
• On Thursday, October 23rd, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $40.18, for a total transaction of $141,433.60.
• On Wednesday, October 22nd, Jack Bendheim sold 11,859 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.27, for a total transaction of $477,561.93.
• On Monday, October 20th, Jack Bendheim sold 16,075 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.38, for a total value of $649,108.50.
• On Friday, October 17th, Jack Bendheim sold 700 shares of Phibro Animal Health stock. The shares were sold at an average price of $40.03, for a total value of $28,021.00.
• On Thursday, September 18th, Jack Bendheim sold 7,022 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.26, for a total value of $282,705.72.
• On Wednesday, September 10th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $41.29, for a total value of $145,340.80.
• On Tuesday, September 9th, Jack Bendheim sold 14,080 shares of Phibro Animal Health stock. The shares were sold at an average price of $40.33, for a total value of $567,846.40.

Phibro Animal Health Stock Performance

Shares of PAHC stock opened at $43.76 on Friday. The firm has a market capitalization of $1.77 billion, a price-to-earnings ratio of 37.09, a PEG ratio of 1.24 and a beta of 0.81. The stock has a fifty day moving average of $39.71 and a 200 day moving average of $30.85. Phibro Animal Health Corporation has a 52 week low of $16.16 and a 52 week high of $44.35. The company has a quick ratio of 1.25, a current ratio of 2.76 and a debt-to-equity ratio of 2.46.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings data on Wednesday, November 5th. The company reported $0.73 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.58 by $0.15. Phibro Animal Health had a net margin of 3.73% and a return on equity of 32.14%. The business had revenue of $363.89 million for the quarter, compared to the consensus estimate of $345.44 million. Phibro Animal Health has set its FY 2026 guidance at 2.640-2.810 EPS. As a group, research analysts expect that Phibro Animal Health Corporation will post 1.95 earnings per share for the current year.

Phibro Animal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 17th. Shareholders of record on Wednesday, November 26th will be issued a $0.12 dividend. The ex-dividend date is Wednesday, November 26th. This represents a $0.48 annualized dividend and a yield of 1.1%. Phibro Animal Health’s dividend payout ratio (DPR) is 40.68%.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on PAHC shares. JPMorgan Chase & Co. upped their target price on Phibro Animal Health from $45.00 to $50.00 and gave the stock an “overweight” rating in a report on Friday. Bank of America upped their price target on Phibro Animal Health from $19.00 to $27.00 and gave the stock an “underperform” rating in a research note on Friday, August 29th. Weiss Ratings raised Phibro Animal Health from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday. Morgan Stanley set a $34.00 target price on shares of Phibro Animal Health in a research report on Thursday, August 28th. Finally, Zacks Research upgraded shares of Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a research note on Monday, September 29th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, three have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $31.40.

Institutional Investors Weigh In On Phibro Animal Health

A number of institutional investors have recently modified their holdings of PAHC. JPMorgan Chase & Co. increased its holdings in shares of Phibro Animal Health by 2.9% during the second quarter. JPMorgan Chase & Co. now owns 13,005 shares of the company’s stock valued at $332,000 after acquiring an additional 363 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Phibro Animal Health by 4.7% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 12,164 shares of the company’s stock valued at $260,000 after purchasing an additional 546 shares during the last quarter. Prospera Financial Services Inc increased its stake in Phibro Animal Health by 3.6% during the 2nd quarter. Prospera Financial Services Inc now owns 19,910 shares of the company’s stock valued at $508,000 after purchasing an additional 690 shares in the last quarter. Harbor Capital Advisors Inc. raised its holdings in Phibro Animal Health by 7.1% in the third quarter. Harbor Capital Advisors Inc. now owns 10,589 shares of the company’s stock worth $428,000 after buying an additional 704 shares during the last quarter. Finally, State of Alaska Department of Revenue raised its holdings in Phibro Animal Health by 7.6% in the second quarter. State of Alaska Department of Revenue now owns 12,129 shares of the company’s stock worth $309,000 after buying an additional 859 shares during the last quarter. 99.34% of the stock is owned by hedge funds and other institutional investors.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.